Tumor Infiltrating Lymphocytes (til) Therapy - Cancer Science

Relevant Publications

Advancements in Tumor-Infiltrating Lymphocytes: Historical Insights, Contemporary Milestones, and Future Directions in Oncology Therapy.

Issue Release: 2024

HLA-A tertiary lymphoid structures with reactivated tumor infiltrating lymphocytes are associated with a positive immunotherapy response in esophageal squamous cell carcinoma.

Issue Release: 2024

Tumor-infiltrating T lymphocytes evaluated using digital image analysis predict the prognosis of patients with diffuse large B-cell lymphoma.

Issue Release: 2024

Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances.

Issue Release: 2024

Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types.

Issue Release: 2024

Clinical presentation of cardiac symptoms following treatment with tumor-infiltrating lymphocytes: diagnostic challenges and lessons learned.

Issue Release: 2024

Tumor-infiltrating lymphocytes: A new hope.

Issue Release: 2024

Dynamic changes in immune cells in humanized liver metastasis and subcutaneous xenograft mouse models.

Issue Release: 2024

Expansion of tumor-infiltrating and marrow-infiltrating lymphocytes from pediatric malignant solid tumors.

Issue Release: 2024

Adoptive T cell therapy for solid tumors: current landscape and future challenges.

Issue Release: 2024

From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma.

Issue Release: 2024

Genetic Modification of Tumor-Infiltrating Lymphocytes, Peripheral T Cells, and T-Cell Model Cell Lines.

Issue Release: 2024

Uncovering the colorectal cancer immunotherapeutic potential: Evening primrose (Oenothera biennis) root extract and its active compound oenothein B targeting the PD-1/PD-L1 blockade.

Issue Release: 2024

GATA3 Positively Correlates with BCL2 Expression in Indolent and Aggressive Histological Types of Cutaneous Basal Cell Carcinoma.

Issue Release: 2024

Developing innovative strategies of tumor‑infiltrating lymphocyte therapy for tumor treatment.

Issue Release: 2024

Persistence and enrichment of dominant T cell clonotypes in expanded tumor-infiltrating lymphocytes of breast cancer.

Issue Release: 2024

Phase Ib trial of IRX-2 plus durvalumab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Issue Release: 2024

Research advances on TIL therapy for colorectal cancer.

Issue Release: 2024

Predictive Factors of Neoadjuvant Chemotherapy Response in Breast Cancer Validated by Three Anatomopathological Scores: Residual Cancer Burden, Chevallier System, and Tumor-Infiltrating Lymphocytes.

Issue Release: 2024

Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma.

Issue Release: 2024

What role do biomarkers play in cancer treatment?

How Do Blister Packs Benefit Cancer Patients?

How to Prepare for Bone Marrow Aspiration?

What are the Benefits of Telemedicine in Cancer Care?

Which Types of Cancer Are Most Commonly Associated with Dysphagia?

How do Keratins Affect Tumor Behavior?

Which Cancers are Associated with MSI-H?

What are the Challenges in Using Natural Compounds for Cancer Treatment?

How is Processed Meat Linked to Cancer?

Why is Tumor Location Important in Cancer?

Partnered Content Networks

Relevant Topics